Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LPM7100328 vs ganirelix in controlled ovarian stimulation
CTR20260665Phase 3Active
- Sponsor
- Yantai Chuanghe Biotechnology
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of LPM7100328 in female infertility, ovulation disorder, sponsored by Yantai Chuanghe Biotechnology. Started Apr 2026; status: active.
02
Drugs
LPM7100328
03
Conditions
female infertilityovulation disorder
Beyond the preview
Go deeper on CTR20260665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20260665.